Turpeinen M
Department of Allergic Diseases, University Central Hospital, Helsinki, Finland.
Br J Dermatol. 1988 Apr;118(4):517-22. doi: 10.1111/j.1365-2133.1988.tb02461.x.
The results of 55 4-h hydrocortisone absorption tests in 38 children with atopic or seborrhoeic dermatitis were analysed to evaluate the effect of age and severity of the dermatitis on percutaneous absorption of hydrocortisone. The children were divided into three groups on the basis of the severity of the dermatitis. The absorption of hydrocortisone caused a significantly higher mean rise of serum cortisol in 20 children with severe dermatitis (Group A) than in 17 children with moderate dermatitis (Group B). The mean post-application rise of serum cortisol in 18 children with mild dermatitis (Group C) was significantly lower than in the children with moderate dermatitis. There was a significant negative linear correlation between age and the post-application rise of serum cortisol in Groups A and C. In these groups the mean post-application rise of serum cortisol was significantly higher in children aged under 18 months than in children aged 18 months or over. Severe widespread dermatitis and an age under 18 months are two relevant risk factors in the topical use of hydrocortisone.
对38例患有特应性皮炎或脂溢性皮炎的儿童进行的55次4小时氢化可的松吸收试验结果进行了分析,以评估年龄和皮炎严重程度对氢化可的松经皮吸收的影响。根据皮炎的严重程度,将儿童分为三组。与17例中度皮炎患儿(B组)相比,20例重度皮炎患儿(A组)中氢化可的松的吸收导致血清皮质醇的平均升高显著更高。18例轻度皮炎患儿(C组)应用后血清皮质醇的平均升高显著低于中度皮炎患儿。A组和C组中,年龄与应用后血清皮质醇升高之间存在显著的负线性相关性。在这些组中,18个月以下儿童应用后血清皮质醇的平均升高显著高于18个月及以上儿童。严重的广泛性皮炎和18个月以下的年龄是局部使用氢化可的松的两个相关危险因素。